npj Digital MedicineBioinformaticsPeer-reviewed journal article
Machine Learning Prediction of Incidence of Alzheimers Disease Using Large-Scale Administrative Health Data
Ji Hwan ParkiD, Han Eol ChoiD, Jong Hun KimiD, Melanie M. WalliD, Yaakov SterniD, Hyunsun LimiD, Shinjae YooiD, Hyoung Seop KimiD, Jiook ChaiD
Abstract
Nationwide population-based cohort provides a new opportunity to build a completely automated risk prediction model based on individuals history of health and healthcare beyond existing risk prediction models. We tested the possibility of machine learning models to predict future incidence of Alzheimers disease (AD) using large-scale administrative health data. From the Korean National Health Insurance Service database between 2002 and 2010, we obtained de-identified health data in elders above 65 years (N=40,736) containing 4,894 unique clinical features including ICD-10 codes, medication codes, laboratory values, history of personal and family illness, and socio-demographics. To define incident AD two operational definitions were considered: "definite AD" with diagnostic codes and dementia medication (n=614) and "probable AD" with only diagnosis (n=2,026). We trained and validated a random forest, support vector machine, and logistic regression to predict incident AD in 1,2,3, and 4 subsequent years. For predicting future incidence of AD in balanced samples (bootstrapping), the machine learning models showed reasonable performance in 1-year prediction with AUC of 0.775 and 0.759, based on "definite AD" and "probable AD" outcomes, respectively; in 2-year, 0.730 and 0.693; in 3-year, 0.677 and 0.644; in 4-year, 0.725 and 0.683. The results were similar when the entire (unbalanced) samples were used. Important clinical features selected in logistic regression included hemoglobin level, age, and urine protein level. This study may shed a light on the utility of the data-driven machine learning model based on large-scale administrative health data in AD risk prediction, which may enable better selection of individuals at risk for AD in clinical trials or early detection in clinical settings.
- organism: human
- assay: electronic health records
- research focus: benchmarking
- research focus: differential expression
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: machine learning (classical)
- Citations
- 148
- FWCI
- 15.02
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identifying incident dementia by applying machine learning to a very large administrative claims dataset
Vijay S. Nori, Christopher A. Hane, … Darshak M. Sanghavi·PLoS ONEPeer-reviewed·Jul 5, 2019
- Quantitative longitudinal predictions of Alzheimer's disease by multi-modal predictive learning
Mithilesh Prakash, Mahmoud Abdelaziz, … Alzheimer’s Disease Neuroimaging Initiative·Journal of Alzheimer s DiseasePeer-reviewed·Jan 12, 2021
- A Novel Ensemble-Based Machine Learning Algorithm To Predict The Conversion From Mild Cognitive Impairment To Alzheimer's Disease Using Socio-demographic Characteristics, Clinical Information And Neuropsychological Measures
Massimiliano Grassi, Nadine Rouleaux, … Alzheimer’s Disease Neuroimaging Initiative·Frontiers in NeurologyPeer-reviewed·Jul 16, 2019
- Mind the Gap: Does Brain Age Improve Alzheimer's Disease Prediction?
Trevor Wei Kiat Tan, Kim‐Ngan Nguyen, … The Australian Imaging Biomarkers and Lifestyle Study of Aging·Human Brain MappingPeer-reviewed·Aug 15, 2025
- Predicting Alzheimer's disease progression trajectory and clinical subtypes using machine learning
Vipul K. Satone, Rachneet Kaur, … Faraz Faghri·bioRxiv·Aug 26, 2020
- A practical computerized decision support system for predicting the severity of Alzheimer’s disease of an individual
Magda Bucholc, Xuemei Ding, … for the Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·Mar 12, 2019